Biospring Partners Closes Debut Fund with $245 Million of Committed Capital to Invest in Life Sciences Technology Companies
/PRNewswire/ -- Biospring Partners, a growth equity firm exclusively focused on B2B life sciences technology companies, today announced the closing of its...
Source: prnewswire.com